Publications

Dynamics of SARS-CoV-2 infection hospitalisation and infection fatality ratios over 23 months in England.

Eales O. et al, (2023), PLoS biology, 21

Sir David Cox—A Life Well Lived

Donnelly CA., (2023), Issue 5.2, Spring 2023, 5

LONG-TERM PHYSICAL AND MENTAL HEALTH IMPACT OF COVID-19 ON ADULTS IN ENGLAND: FOLLOW UP OF A LARGE RANDOM COMMUNITY SAMPLE

Atchison CJ. et al, (2023)

Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19.

Kartsonaki C. et al, (2023), International journal of epidemiology, 52, 355 - 376

The use of representative community samples to assess SARS-CoV-2 lineage competition: Alpha outcompetes Beta and wild-type in England from January to March 2021.

Eales O. et al, (2023), Microbial genomics, 9

The uncertainty of infectious disease outbreaks is underestimated

Penn M. et al, (2023)

Understanding the incidence and timing of rabies cases in domestic animals and wildlife in south-east Tanzania in the presence of widespread domestic dog vaccination campaigns

Hayes S. et al, (2022), Veterinary Research, 53

Population antibody responses following COVID-19 vaccination in 212,102 individuals

Ward H. et al, (2022), Nature Communications, 13

Symptom‐based case definitions for COVID‐19: Time and geographical variations for detection at hospital admission among 260,000 patients

Baruch J. et al, (2022), Influenza and Other Respiratory Viruses, 16, 1040 - 1050

Trends in SARS-CoV-2 infection prevalence during England's roadmap out of lockdown, January to July 2021.

Eales O. et al, (2022), PLoS computational biology, 18

Quantifying changes in the IFR and IHR over 23 months of the SARS-CoV-2 pandemic in England

Eales O. et al, (2022)

Omicron SARS-CoV-2 epidemic in England during February 2022: A series of cross-sectional community surveys.

Chadeau-Hyam M. et al, (2022), The Lancet regional health. Europe, 21

Quantifying the information in noisy epidemic curves

Parag KV. et al, (2022), Nature Computational Science, 2, 584 - 594

Respiratory support in patients with severe COVID-19 in the International Severe Acute Respiratory and Emerging Infection (ISARIC) COVID-19 study: a prospective, multinational, observational study

Reyes LF. et al, (2022), Critical Care, 26

The impact of repeated rapid test strategies on the effectiveness of at-home antiviral treatments for SARS-CoV-2

Menkir TF. and Donnelly CA., (2022), Nature Communications, 13

Appropriately smoothing prevalence data to inform estimates of growth rate and reproduction number.

Eales O. et al, (2022), Epidemics, 40

Stochastic modelling of African swine fever in wild boar and domestic pigs: Epidemic forecasting and comparison of disease management strategies.

Dankwa EA. et al, (2022), Epidemics, 40

The African swine fever modelling challenge: Model comparison and lessons learnt.

Ezanno P. et al, (2022), Epidemics, 40

Dynamics of a national Omicron SARS-CoV-2 epidemic during January 2022 in England.

Elliott P. et al, (2022), Nature communications, 13

Measuring Vaccine Efficacy Against Infection and Disease in Clinical Trials: Sources and Magnitude of Bias in Coronavirus Disease 2019 (COVID-19) Vaccine Efficacy Estimates.

Williams LR. et al, (2022), Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 75, e764 - e773

Validity of self-testing at home with rapid SARS-CoV-2 antibody detection by lateral flow immunoassay.

Atchison CJ. et al, (2022), Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19

Abbas A. et al, (2022), Scientific Data, 9

Dynamics of competing SARS-CoV-2 variants during the Omicron epidemic in England.

Eales O. et al, (2022), Nature communications, 13

SARS-CoV-2 lineage dynamics in England from September to November 2021: high diversity of Delta sub-lineages and increased transmissibility of AY.4.2.

Eales O. et al, (2022), BMC infectious diseases, 22

A platform trial design for preventive vaccines against Marburg virus and other emerging infectious disease threats.

Longini IM. et al, (2022), Clinical trials (London, England)

Twin peaks: The Omicron SARS-CoV-2 BA.1 and BA.2 epidemics in England.

Elliott P. et al, (2022), Science (New York, N.Y.), 376

Validity of self-testing at home with rapid SARS-CoV-2 antibody detection by lateral flow immunoassay

Atchison CJ. et al, (2022)

Asymptotic analysis of optimal vaccination policies

Penn MJ. and Donnelly CA., (2022)

Breakthrough SARS-CoV-2 infections in double and triple vaccinated adults and single dose vaccine effectiveness among children in Autumn 2021 in England: REACT-1 study.

Chadeau-Hyam M. et al, (2022), EClinicalMedicine, 48

Are epidemic growth rates more informative than reproduction numbers?

Parag KV. et al, (2022), Journal of the Royal Statistical Society. Series A, (Statistics in Society)

Variant-specific symptoms of COVID-19 among 1,542,510 people in England

Whitaker M. et al, (2022)

Optimality of Maximal-Effort Vaccination

Penn MJ. and Donnelly CA., (2022)

Quantifying the information in noisy epidemic curves

Parag KV. et al, (2022)

Fundamental limits on inferring epidemic resurgence in real time using effective reproduction numbers

Parag KV. and Donnelly CA., (2022), PLOS Computational Biology, 18, e1010004 - e1010004

Global, regional, and national minimum estimates of children affected by COVID-19-associated orphanhood and caregiver death, by age and family circumstance up to Oct 31, 2021: an updated modelling study.

Unwin HJT. et al, (2022), The Lancet. Child & adolescent health, 6, 249 - 259

Global, regional, and national minimum estimates of children affected by COVID-19-associated orphanhood and caregiver death, by age and family circumstance up to Oct 31, 2021: an updated modelling study

Unwin HJT. et al, (2022), LANCET CHILD & ADOLESCENT HEALTH, 6, 249 - 259

SARS-CoV-2 infection and vaccine effectiveness in England (REACT-1): a series of cross-sectional random community surveys.

Chadeau-Hyam M. et al, (2022), The Lancet. Respiratory medicine, 10, 355 - 366

Rapid increase in Omicron infections in England during December 2021: REACT-1 study.

Elliott P. et al, (2022), Science (New York, N.Y.), 375, 1406 - 1411

Appropriately smoothing prevalence data to inform estimates of growth rate and reproduction number

Eales O. et al, (2022)

The impact of repeated rapid test strategies on the effectiveness of at-home antiviral treatments for SARS-CoV-2

Menkir TF. and Donnelly CA., (2022)

Analysis of a double Poisson model for predicting football results in Euro 2020.

Penn MJ. and Donnelly CA., (2022), PloS one, 17

Authors' reply to the discussion of 'Are epidemic growth rates more informative than reproduction numbers?' by Parag et al. in Session 1 of the Royal Statistical Society's Special Topic Meeting on COVID-19 transmission: 9 June 2021

Parag KV. et al, (2022), JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY

Clinical characteristics, risk factors and outcomes in patients with severe COVID-19 registered in the International Severe Acute Respiratory and Emerging Infection Consortium WHO clinical characterisation protocol: a prospective, multinational, multicentre, observational study.

Reyes LF. et al, (2022), ERJ open research, 8, 552 - 2021

Tracking the incidence and risk factors for SARS-CoV-2 infection using historical maternal booking serum samples.

Mullins E. et al, (2022), PloS one, 17

Exponential growth, high prevalence of SARS-CoV-2, and vaccine effectiveness associated with the Delta variant.

Elliott P. et al, (2021), Science (New York, N.Y.), 374

Disease transmission and control modelling at the science–policy interface

McCabe R. and Donnelly CA., (2021), Interface Focus, 11

Communicating uncertainty in epidemic models.

McCabe R. et al, (2021), Epidemics, 37

Deciphering early-warning signals of SARS-CoV-2 elimination and resurgence from limited data at multiple scales

Parag KV. et al, (2021), Journal of The Royal Society Interface, 18

Estimating vaccination threshold and impact in the 2017-2019 hepatitis A virus outbreak among persons experiencing homelessness or who use drugs in Louisville, Kentucky, United States.

Dankwa EA. et al, (2021), Vaccine, 39, 7182 - 7190

Geographical drivers and climate-linked dynamics of Lassa fever in Nigeria

Redding DW. et al, (2021), Nature Communications, 12

Cookies on this website

Publications